Regulation of matrix metalloproteinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium

Patricia B. Cornet, Christine Galant, Yves Eeckhout, Pierre J. Courtoy, Etienne Marbaix, Étienne Marbaix, Patrick Henriet
The Journal of clinical endocrinology and metabolism · 2005 · vol. 90(2) , pp. 1001–1011 · doi:10.1210/jc.2004-1277 · PMID:15536155 · W2059912978
Lab / animal OA: bronze CC0 ⤵ 16 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study quantified human endometrial MMP-9 expression and found its activity is controlled by ovarian steroids and modulated by LEFTY-A, with increased MMP-9 mRNA coinciding with menstruation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Various matrix metalloproteinases (MMPs) participate in the menstrual breakdown of the human endometrium. MMP-9/gelatinase B is proposed as a major factor because it degrades many extracellular matrix constituents, including in the vasculature. Although globally under ovarian steroids control, endometrial MMP-9 seems expressed differently than other MMPs, and conflicting publications prevent a clear understanding of its regulation. We therefore quantified MMP-9 expression in the cycling human endometrium, defined its localization, and analyzed its regulation by estradiol and progesterone and by LEFTY-A/endometrial bleeding-associated factor in explant cultures. In fresh tissues, a major increase in MMP-9 mRNA expression occurred at menstruation, after a larger increase in LEFTY-A mRNA. MMP-9 was immunodetected in all cell types throughout the cycle, especially in foci of stromal cells during menstruation. MMP-9 synthesis by these cells was confirmed in cultured explants. In proliferative explants, ovarian steroids slightly decreased MMP-9 mRNA. They had no consistent effect on MMP-9 release in culture medium but strongly inhibited proMMP-9 activation. Addition of recombinant LEFTY-A to explants induced MMP-9 in most samples, a response prevented by ovarian steroids. We propose that endometrial MMP-9 activity is overall controlled by the ovarian steroids and locally adjusted through a network of modulators, including LEFTY-A.

My notes (saved in your browser only)

MeSH descriptors

Endometrium Matrix Metalloproteinase 9 Transforming Growth Factor beta Base Sequence Biopsy Cells, Cultured DNA Primers Endometrium Endometrium Endometrium Endometrium Female Gene Expression Regulation, Enzymologic Gene Expression Regulation, Enzymologic Humans Left-Right Determination Factors Matrix Metalloproteinase 9 Menstrual Cycle Menstrual Cycle Ovary

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (50)

Cited by (16)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:02:47.667321+00:00
License: CC0 · commercial use OK